About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Los Angeles | 4,632 Studies Near You

Clinical TrialsLos Angeles

Clinical Trials in Los Angeles

Discover 4,632 clinical trials near Los Angeles, California. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3461-3480 of 4,632 trials

CompletedEffects of Inhibiting Early Inflammation in Kidney Transplant PatientsDuring transplant surgery, there is a period of time when a donated kidney is removed from a donor's body and stored until the time of the transplant surgery.NCT02495077·Birmingham, Alabama and 14 others CompletedDose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected IndividualsThe purpose of this research study is to determine which of three different dose combinations of tipranavir and ritonavir, when taken with a standard approved anti-HIV drug…NCT00034866·Phoenix, Arizona and 50 others

Find Trials by Condition in Los Angeles

Breast Cancerin Los Angeles Lung Cancerin Los Angeles Prostate Cancerin Los Angeles Colorectal Cancerin Los Angeles Melanomain Los Angeles Leukemiain Los Angeles Lymphomain Los Angeles Pancreatic Cancerin Los Angeles Ovarian Cancerin Los Angeles Brain Cancerin Los Angeles

Data from ClinicalTrials.govTerms

CompletedSwitch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDFThis study will evaluate the efficacy of switching from emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) fixed dose combination (FDC) to emtricitabine/tenofovir alafenamide…NCT02121795·Birmingham, Alabama and 77 others

CompletedStudy of MEK162 for Children With Low-Grade GliomasThe goal of this clinical trial is to study the drug MEK162 in children with a brain tumor call low-grade glioma, as well as in children with other tumors in which a specific…NCT02285439·Birmingham, Alabama and 14 others

SuspendedTesting the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar CarcinomaThis phase I/II trial tests the safety, side effects and best dose of DT2216 in combination with irinotecan and how well it works in treating children, adolescents and young…NCT06620302·Birmingham, Alabama and 20 others

TerminatedStudy to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM SubjectsThe purpose of this study is to assess the safety and tolerability of VBI-1901 in subjects with recurrent malignant gliomas (glioblastoma, or GBM).NCT03382977·Irvine, California and 11 others

Active not recruitingPrescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical TrialThe aim of this study is to inform and improve future clinical trials in Wilson Disease (WD) by better understanding how patients with WD are living with and managing the disease…NCT07226622·Los Angeles, California and 6 others

TerminatedEfficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast CancerSTAGE 1: To determine the safety of enobosarm 9 milligram (mg) once daily (QD) used in combination with a CDK 4/6 inhibitor \[Verzenio® (abemaciclib) tablets, for oral use, 150 mg…NCT05065411·Chandler, Arizona and 29 others

CompletedDialysis Clinical Outcomes Revisited (DCOR) TrialThis is a randomized, open-label, parallel-design study to be conducted at 75 centers within the United States. The study will be described to hemodialysis patients.NCT00324571·Gadsden, Alabama and 72 others

Active not recruitingPevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid LeukemiaThis phase Ib/II trial studies the side effects and best dose of pevonedistat and to see how well it works in combination with cytarabine and idarubicin in treating patients with…NCT03330821·Tucson, Arizona and 4 others

CompletedSafety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast CancerThe purpose of this trial is to determine the efficacy and safety profile of TKI258 in 3 groups of patients with metastatic HER2 negative breast cancer (BC) stratified by FGFR1…NCT00958971·Bakersfield, California and 37 others

TerminatedTemsirolimus in Treating Patients With Recurrent or Persistent Cancer of the UterusThis phase II trial is studying how well temsirolimus works in treating patients with recurrent or persistent cancer of the uterus.NCT01061606·Beverly Hills, California and 19 others

CompletedImproving Basic and Social Cognition in Veterans With SchizophreniaVeterans with schizophrenia and schizoaffective disorder experience very high levels of disability and poor community outcome.NCT00470106·West Los Angeles, California

CompletedA Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)The study is a Phase II randomized, open label, multicenter trial designed to identify whether sirolimus is a potential alternative to prednisone as an up-front treatment for…NCT02806947·Duarte, California and 20 others

RecruitingA Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaGlioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/III response adaptive randomization platform trial designed…NCT03970447·Birmingham, Alabama and 62 others

CompletedA Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial CancerThis is a prospective, multi-center, open-label, single-arm, non-randomized, Phase II study to evaluate the efficacy and safety of TKI258 as second-line therapy in patients with…NCT01379534·Mobile, Alabama and 44 others

CompletedTiming of Inguinal Hernia Repair in Premature InfantsThe purpose of this study is to determine whether early (before NICU discharge) or late (55-60 weeks post-menstrual age) inguinal hernia repair is safer for premature infants who…NCT01678638·Birmingham, Alabama and 39 others

CompletedSafety of Low Dose IV Contrast CT Scanning in Chronic Kidney DiseaseThe purpose of this study is to show that the use of low volume iso-osmolar non-ionic radio contrast medium (30 cc) in a thoracic CT Scanning procedure in a selected group of…NCT02476526·Los Angeles, California

Active not recruitingPhase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)A Phase I-II, First-in-Human Study of SKB264 (Sac-TMT; MK-2870) in Patients with Locally Advanced Unresectable/Metastatic Solid Tumors who are refractory to Available Standard…NCT04152499·Glendale, California and 108 others

WithdrawnMolecular Signatures of Relapse in Tissue Samples From Patients With Small Cell Lung Cancer Who Are Receiving Cisplatin and EtoposideThis pilot research trial studies molecular signatures of the return of cancer after a period of improvement (relapse) in tissue samples from patients with small cell lung cancer…NCT02250404·Los Angeles, California and 1 other

PreviousPage 174 of 232Next

Diabetes

in Los Angeles

Heart Diseasein Los Angeles